[Translation] A Phase 3 Multicenter, Placebo- and Active-Controlled, Randomized, Double-Blind, 12-Week Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients with High TG and Low HDL-C
本研究是一项3期、多中心、活性和安慰剂对照、随机、双盲、平行组研究,目的是评估与安慰剂和非诺贝特相比,K-877对高TG、低HDL-C的血脂异常患者的有效性和安全性。
[Translation] This study is a Phase 3, multicenter, active and placebo-controlled, randomized, double-blind, parallel-group study to evaluate the effect of K-877 on high TG, low HDL- Efficacy and safety in patients with dyslipidemia of C.